Gene Therapy Market to grow in future by size, developments, trends by 2026

1. Gene therapy is being extensively used to treat several diseases like cancer, cystic fibroses, heart diseases, diabetes, AIDS, and Hemophilia. Increasing popularity of gene therapy owes to the provision of complete cure to patients affected with genetic and other life- threatening disorders. One of the major factors driving growth for the gene therapy market is the growing cancer cases on a global scale. Numerous gene therapy strategies have been developed. For example: oncolytic virotherapy, correction of gene defects, genetic manipulation of apoptotic and tumor invasion pathways, gene therapy-based immune modulation, and RNAi strategies. These treatments target cancers affecting lungs, brain, pancreas, skin, and ovaries Onslaught of the COVID-19 pandemic has accelerated the application of gene therapy. Technology for gene and cell therapy is anticipated to be excessively applied for developing vaccines. In January 2019, Mass General Brigham developed vaccine candidates which stimulated convincing immune responses from animal models in treatment of the novel coronavirus. The vaccine candidate named AAVCOVID, was developed through gene- therapy technology and received a grant of USD 2.1 Million for further research. Similarly, researchers from the University of Pennsylvania have started using adeno-associated viral vectors to transmit lab-made antibodies into the body. Looking For a Sample Copy of This Report? Request the Same Here: https://www.fairfieldmarketresearch.com/report/gene-therapy-market/request-sample Increasing Incidence of Cancer Facilitates Gene Therapy Market Growth Gene therapy encompasses an advanced medical treatment for numerous chronic and genetic disorders in humans. This is achieved by replacing a defective gene cell with a healthy gene cell. Through gene therapy, chronic and genetic disorders that do not have developed cures can be prevented. Developers of gene therapy are quickly expanding their

2. businesses through acquisitions and mergers. New product launch deals are being signed as a strategy to strengthen product trails and augment in-house proficiency. Researchers are increasingly finding investments to enhance the process of transferring genes into cancer cells. The carrier that takes genes into cancer cells is called a vector. Viruses can enter cells and deliver genetic material once they are altered in a way that cannot result in any serious disorder. Therefore, they are the most common types of carriers used in gene therapy. Due to these factors, the market for gene therapy is expected to experience a sturdy growth. Do You Have Any Query or Specific Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/gene-therapy-market/request- customization North America Forecasted to Dominate Global Gene Therapy Market The US Department of Health and Human Services has been appointed to oversee clinical trials of gene therapy. These treatments have been securing approvals from government organizations like the US FDA, OHRP, and CFR. Increasing developments in gene therapy strategies in the United States of America is augmenting the market growth in the North American region. Big pharma companies are collaborating and initiating acquisitions in order to cash in on these growing opportunities. The global gene therapy market consists of a few key players. Major companies hold a considerable collective share in the global market. These include Uniqure NV, Orchard Therapeutics, Spark Therapeutics (Roche AG), Sibiono GeneTech, Novartis AG, Bluebird Bio, Gilead Sciences inc., and Amgen inc. About Us Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness. Contact Fairfield Market Research London, UK UK +44 (0)20 30025888 USA (Toll-free) +1 (844) 3829746 Web: https://www.fairfieldmarketresearch.com/ Email: sales@fairfieldmarketresearch.com Follow Us: LinkedIn